|
|
 |
|
Viewing report
|
|
|
|
Emerging Markets for Clinical Trials in India - Favorable Regulatory Environment and Cost Effectiveness Will Accelerate the Number of Clinical Trials
GBI Research, Jan 2011, Pages: 96
Emerging Markets for Clinical Trials in India - Favorable Regulatory Environment and Cost Effectiveness Will Accelerate the Number of Clinical Trials
Summary
GBI Research’s new report, “Emerging Markets for Clinical Trials in India - Favorable Regulatory Environment and Cost Effectiveness Will Accelerate the Number of Clinical Trials”, provides in-depth analysis of trends, issues and challenges in this industry. The report analyzes the effective strategies that shape the industry dynamics. The report also provides comprehensive insight into the clinical trials cost, infrastructure, regulations and key drivers and barriers that impact the clinical trials market in India. Further, the report provides competitive benchmarking for the leading companies that shape the Indian clinical trials market. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.
Scope
The scope of this report includes:
- Annualized data from 2001 to 2009, forecast forward to 2016.
- Market characterization, including market size
- Analysis of the leading therapeutic areas under clinical research in India
- Key drivers and barriers that have a significant impact on the clinical trials market.
- Competitive benchmarking of leading companies.
- Key M&A activities and strategic partnership deals that have taken place in 2009
Reasons to buy
The report will enhance your decision making capability. It will allow you to
- Align your product portfolio to the markets with high growth potential.
- Develop market-entry and market expansion strategies by identifying the leading therapeutic segments poised for strong growth.
- Device a more tailored country strategy through the understanding of key drivers and barriers in conducting clinical trial in the country.
- Develop key strategic initiatives by understanding the key focus of clinical research of leading companies.
- Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.
|
|
|
|
